COMP <GO>
LQDA vs LLY // ALTMAN Z-SCORE & DEBT/EQUITY
Liquidia Corporation (NASDAQ) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: LQDA 4
— LLY 10
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: LLY
LAST: $45.06 (+0.16%) • MKT CAP: $4.03B
balance-sheet
6.33
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
balance-sheet
9.29
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LQDA VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LQDA | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 83.64% | -42.64 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -12.60% | 32.36% | -44.96 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 36.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.99% | 2.30% | -3.29 | LLY | /fcf-yield <GO> |
| Operating Margin | -32.50% | 40.21% | -72.71 | LLY | /operating-margins <GO> |
| Net Profit Margin | -43.50% | 31.90% | -75.40 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | 45.51% | +134.49 | LQDA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 6.33 | 9.29 | -2.96 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 9/9 | -4.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.77% | -0.17 | LQDA | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.5 | 77.9 | -25.35 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 0.51 | +0.39 | LQDA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.0x | 26.3x | -5.25 | LQDA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.03B | $1.33T | -$1.33T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LQDA REV | LLY REV | LQDA GROSS % | LLY GROSS % | LQDA FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $158.3M | $65.18B | 44.0% | 83.0% | -$40.0M | $16.81B |
| FY 2024 | $14.0M | $45.04B | 58.0% | 81.3% | -$98.4M | $8.82B |
| FY 2023 | $17.5M | $34.12B | 44.0% | 79.3% | -$42.4M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LQDA // BETA 0.90
LLY // BETA 0.51